MMAI Gym
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
What it does
- Model training
- Evaluation and observability
- Drug discovery
- Agent orchestration
Features 3
- LLM training routineTrains a customer's LLM on Insilico's proprietary data, reasoning datasets and validated models to boost drug discovery tasks.
- Experimental validation in automation labModel output can be experimentally validated in Insilico's automation lab.
- Three-month training subscriptionSubscribers get a 3-month training session during which the model's benchmark performance is tracked.
Sources
- Pricing
-
Official documentation · 3 Sep 2026
Customers bring their own LLM or use Insilico's open foundation models; booking-based engagement, no published rates.
- Constraints
-
Official documentation · 2 Oct 2026
Derived from the security facts on this page, from the same source.
- Security
-
Official documentation · 2 Oct 2026
Company-wide Security & IT page covering client data and IP across engagements, applied to all listed products (page names none individually). ISO 27001 refers to the ISMS. Residency is client-chosen cloud servers, recorded as custom. Training, ZDR, DPA not stated.
- Sold within
-
Live re-check 2026-09-15: insilico.com/mmai shows MMAI Gym consistently nested under the "Pharma.ai Suite" nav menu, positioned as one offering within the Pharma.ai ecosystem rather than independent; pharma.ai/mmai itself returns HTTP 404.
- Intended for
-
"A training ground for LLMs... to boost the LLM's intelligence in drug discovery and development related tasks"; page is built around benchmarks and bioRxiv publications (LongevityBench, TID-Pro) aimed at scientific researchers.
Also from Insilico Medicine
-
Pharma.AI Platform
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
-
PandaOmics Platform
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base; also answers literature-review questions through ChatPandaGPT.
-
PandaOmics Box Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
-
Chemistry42 Platform
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
-
Biology42: Generative Biologics Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
-
inClinico Application
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
-
Science42: DORA Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
Open Insilico Medicine in the directory
Something wrong here? Send a correction — quote this product id: insilico-medicine-mmai-gym.